Protein Depletion Assay is fundamentally reshaping the landscape of modern drug discovery. Unlike traditional "occupancy-driven" small molecule inhibitors, target protein depletion molecules utilize an "event-driven" mechanism. They hijack the cell's internal ubiquitin-proteasome system to completely degrade and clear disease-causing proteins, opening new doors for traditionally "undruggable" targets.

Accurate, sensitive, and reproducible target protein depletion assays are essential for evaluating drug efficacy, guiding structural optimization, and advancing your pipeline. Creative Diagnostics offers a one-stop bioassay platform designed to reveal the true activity and kinetics of your degraders within a realistic cellular microenvironment.
Backed by extensive hands-on experience in the TPD field, our technical team provides customized support throughout your entire preclinical R&D cycle. To fully profile your degrader molecules, we utilize a multi-dimensional technology matrix covering everything from biochemical interactions to cellular phenotypes:
We analyze your target characteristics and degrader type to customize a cost-effective and scientifically rigorous assay strategy.
We build cell models specific to your project and determine the optimal reagent ratios, incubation times, and detection windows.
We perform standardized assays at your requested scale, ensuring data stability and reproducibility both within and across batches.
We deliver a comprehensive report featuring detailed methodologies, degradation kinetics curves, raw data, and expert conclusions.